Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Chugai describes OWL-833, an orally active non-peptide GLP-1 receptor agonist

June 27, 2018

Enteris reports results from final arm of phase IIa trial of Ovarest

June 27, 2018

Phase III EASE-2 and EASE-3 trials of empagliflozin in type 1 diabetes meet primary endpoint

June 26, 2018

Crinetics Pharmaceuticals awarded NIDDK grants

June 25, 2018

Dual MetAP 2/DPP-IV inhibitors identified at Lilly

June 22, 2018

FDA approves use of Cinryze to prevent angioedema attacks in pediatric patients with HAE

June 21, 2018

Atossa completes dosing in phase I study of topical endoxifen

June 21, 2018

New phase II trial studies arimoclomol for Gaucher's disease

June 21, 2018

Allena Pharmaceuticals completes preclinical proof-of-concept study for ALLN-346

June 20, 2018

Boehringer Ingelheim identifies free fatty acid receptor 1 agonists

June 20, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...